Stay updated on SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change is a metadata/version update and does not modify the reported study details.
    Difference
    0.0%
    Check dated 2026-08-06T20:41:01.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 on the page. This reflects a new page version rather than changes to substantive content.
    Difference
    0.0%
    Check dated 2026-07-23T11:56:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.3, replacing the previous Revision: v3.6.1, indicating a newer version reference for an internal document or component on the page.
    Difference
    0.0%
    Check dated 2026-07-02T03:15:35.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated from v3.6.0 to v3.6.1, indicating a minor release label. The content and structure of the page remain the same apart from the version label.
    Difference
    0.0%
    Check dated 2026-06-25T00:07:06.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Recruitment status updated and new study sections added, with a revised Intervention/Treatment area and a version note (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-16T20:10:21.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning. No substantive changes to study information or layout are implied.
    Difference
    0.0%
    Check dated 2026-06-09T14:51:51.000Z thumbnail image

Stay in the know with updates to SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.